Special problems of university research concern the allocation of staff and funds from 'teaching' resources, funding 'pilot' experiments from University Grants Committee allocations before submission to the peer review inherent in the present granting system and the problem of indirect costs. Special problems of long-term research might be partially resolved if research councils gave more five-year support than is the custom at present. Three-year support renders today's working scientist and his technicians increasingly security-conscious and limits the effective research time to two years or even less for any given project. Smaller research bodies and charitable trusts might make a greater contribution by concentrating rathet than diffusing their support.
Professor C A Vernon (Department ofChemistry, University College, London WCI)
Biological Chemistry in the University
Any activity in which chemical techniques and concepts are used in an attempt to achieve some specific biological goal or to understand some biological phenomenon can be called biological chemistry. Obvious examples are: (a) enzymology, in so far as this is concerned with understanding the origin of the catalysis produced by enzymes; (b) isolation and the determination of the structure of naturally occurring peptides with interesting pharmacological activities; and (c) isolation of particular 'receptors' using specific blocking agents (for example, the use of a-bungarotoxin in the isolation of the postsynaptic acetylcholine receptor). Many chemistry departments now have groups working in this general field and, for various reasons, this seems likely to become more common in the future.
One problem is to achieve sufficient contact with colleagues in the relevant neighbouring fieldsbiology, medicine and so on. No interdisciplinary research can be successful without meaningful discourse between workers trained in the relevant disciplines. In a sense the university departmental system is ill suited to the needs of contemporary science since many of the most fruitful areas of research fall between traditional disciplines.
Another problem is, inevitably, finance. The research councils have, on the whole, done their best to finance worthwhile projects. However, there are many issues which need to be raised. Should the available finance be given mainly to fairly large established groups or should it be spread widely over all departments? Is the present three-year term of support sufficiently long? Should certain areas of research be specifically promoted by extra financial assistance? Are the present arrangements for contacts between groups working in the same field sufficient?
Professor T Symington (Institute ofCancer Research, London SW3)
Problems of Biological and Paraclinical Research Within the Environment of a Research Institute Structure
A number of research institutes in the past have been financed mainly by grants in aid from grantgiving agencies and by legacies from the public. In the case of the Institute of Cancer Research, within the next four years the grant in aid will be halved to provide a basic block grant and the remainder of the money will have to be won on the basis of three to five year programmes and project support.
However a research institute is financed, there is a need to establish basic posts which will carry tenure. This raises the problem of the career structure of a research institute, the need for redeployment of research staff and, in particular, the place of the young scientist in research institutes.
Where a research institute is involved in both fundamental and applied biomedical research special problems are encountered. There is a need to form a bridge between the hospital bed and the research institute, and this involves the training of suitable medical staff in science technology and a need to familiarize the scientist with the problems of human disease. It is difficult for someone already trained in science to go back and take a long course in medicine. Are our present curricula in medicine and science too rigid and should they be organized so that the first two years of a biological and a medical training would be the same?
The siting of biomedical research institutes in the future must be given serious consideration if proper attention is to be paid to the training of both medicals and scientists. Should, therefore, such institutes be sited within a university medical campus? Section ofComparative Medicine 3 Dr P 0 Williams commented on the criticism by the speakers of the departmental structure and of bridging the gap between basic and clinical sciences. He thought that the exploration of the problem of interdisciplinary research presented the greatest opportunity today.
Professor W S Peart said that it was impossible to interest biomedical research scientists in the common diseases unless the right questions were posed. Teaching would not provide the bridge; the requirement was for people qualified in medicine with adequate scientific training. For example such people should have an MRCP in addition to a BSc and should work for three years for a PhD in a scientific department.
The President suggested that the geographical location of medical schools on the same campus as scientific establishments would help to overcome lack of communication. Dr S G Owen said that financial support for nonclinical staff was not sufficient; they required respect. Award-giving bodies were too often suspicious of interdisciplinary projects.
Professor S V Perry said that because of the present career structure a clinician could not spend too much time in a biochemistry department, and a biochemist could not spend too much time in a department of medicine. Alteration was required in the faculty and departmental structure of universities.
Professor C A Vernon thought that the departmental structure in British universities was very strong, but that it could be and had been bypassed by carrying out within one department research appropriate to another.
Miss 0 Uvarov asked about the formation of clinical pharmacology centres where there could be an extension of research into clinical pharmacology, the methodology for evaluating therapeutics, and further studies on epidemiology.
Dr J M G Wilson said that in nonclinical health care there was a readiness for people of different disciplines to collaborate. In addition the structure of the National Health Serviceprobably aided this type of research.
Dr L E Glynn (Canadian Red Cross Memorial Hospital, Taplow, Maidenhead, Berkshire)
The Financial Support for Rheumatism Research Sources of financial support in this country for research into the rheumatic diseases fall into two groups, specific and nonspecific. There are two specific sources: The Arthritis and Rheumatism Council for Research and the Oliver Bird Fund administered by the Nuffield Foundation.
The Arthritis and Rheumatism Council has evolved from its precursor the Empire Rheumatism Council and, from extremely modest beginnings between the two world wars, has now become by far the largest single source of funds for rheumatism research. Its distribution for this purpose approached £400 000 in 1971. It derives its funds entirely from voluntary contributions collected by the endeavours of some 300 branches which cover most of the United Kingdom. Its activities are controlled by a series of subcommittees of which the most important, from the consumer's point of view, is the Research Subcommittee of the Scientific Coordinating Committee. All applications for grants are assessed in depth by this committee and in most instances this involves an interview of the applicants by the whole Subcommittee. In addition to specific project grants, block grants are occasionally made to individuals or institutions of repute. Although the funds are mostly used for equipment, for both scientific and technical assistance, and for running costs, help with new buildings is not excluded. Since 1967 the Council's major financial obligation has been its support of the Mathilda and Terence Kennedy Institute of Rheumatology. This now consumes almost 50% of the Council's budget.
The Oliver Bird Fund is derived from a bequest by the late Captain Oliver Bird and in accordance with its terms is used entirely for rheumatism research. All applications for grants from this fund are assessed by a special rheumatism committee set up by the Nuffield Foundation. Its annual distribution is about £60 000 and although money for buildings has been granted preference is given to applications not requiring such capital expenditure. Money for rheumatism research from the Nuffield Foundation is not, at least in theory, restricted to the Oliver Bird Fund, although in practice the Fund usually suffices for the demands made upon it. Personal interviews by the committee are not undertaken although the opinions of refereees are sometimes sought.
